A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

NCT06937749 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions

DRUG: Placebo
DRUG: IBI362

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.